BRC News

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its ‘Phase 3’ trials which involved UCLH that show its candidate vaccine is effective at preventing COVID-19 and offers a high level of protection.

The team at UCLH, UCL and Mercedes HPP that developed a life-saving breathing device at the height of the pandemic has been shortlisted for the 2020 HSJ Award for Acute Innovation of the Year.

More ‘Generation Z’ boys and girls in the UK are dieting to lose weight than in previous generations, and are likely to overestimate their own weight, finds a new UCL-led study.

A three year plan to improve the health and lives of people living with obesity has been launched by the Obesity Empowerment Network (OEN UK), which was co-founded by the BRC’s Obesity theme lead Professor Rachel Batterham.

A simple new blood test that could speed up drug discovery for the treatment of a type of inherited ataxia has been developed by researchers from the Ataxia Centre at UCL Queen Square Institute of Neurology and from Mayo Clinic in Florida.

The BRC has published a magazine for patients and the public on the latest COVID-19 research at UCLH. 

More than two-thirds of patients hospitalised due to COVID-19 continue to suffer from debilitating symptoms more than seven weeks after being discharged, according to a new study carried out at University College London Hospitals NHS Trust (UCLH), Barnet Hospital, and the Royal Free Hospital.

UCLH is the first hospital in the world to treat a Covid-19 patient with nebulised (inhaled) surfactant – a substance which makes it easier to breathe – as part of a clinical trial. Lung surfactant is a substance that reduces the work of breathing and prevents the lungs from collapsing. In some

People with COVID-19 who experience a stroke appear to be left with greater disability after the stroke, according a study led by UCL and UCLH researchers.

Professor Sir Alimuddin (Ali) Zumla has led efforts to tackle Covid-19 internationally from the very start of the pandemic. Read our profile of Sir Ali and his work.

Fears that people with high blood pressure are more at risk from severe Covid-19 have been laid to rest, thanks to research involving UCLH.

Elevated risk of Parkinson’s disease among people with type 2 diabetes appears to be reduced by some medications used to treat their diabetes, finds a new study led by UCL researchers.

Researchers have reported for the first time on a patient who developed sudden irreversible hearing loss after being hospitalised for Covid-19.

UCLH has recruited the first patient to a trial that will look at whether giving blood plasma to patients hospitalised with severe Covid-19 infection can reduce illness severity and mortality.

UCLH is the first site to recruit a patient to a national urgent public health study analysing viral genomic data in real time to reduce the spread of Covid-19 in hospitals.